Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Food & Drug Administration (2021) FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes, U.S
The Science: What Research Shows About IV Therapy You might wonder if IV therapy really works or if it's just hype
These combined mechanisms create a comprehensive metabolic effect that extends beyond glucose lowering
A personalized approach is the hallmark of a successful journey
By overexpressing tight junction proteins and maintaining the blood-brain barrier (BBB) integrity, short-chain fatty acids (SCFA) can penetrate the BBB via monocarboxylate transporters (MCTs) (67)
The cells were then washed three times with PBS containing 1% BSA (w/v) followed by 1 h incubation with 1:1,000 anti-mouse Alexa Fluor 488 conjugated secondary antibody (diluted with PBS containing 5% BSA, Invitrogen) at RT in the dark
US$ 21.71
US$ 25.20
US$ 24.58
US$ 24.11
US$ 23.56
